Cadila Healthcare recalls Atenolol tablets from US market

31 Mar 2017 Evaluate

Cadila Healthcare is recalling 9,561 bottles Atenolol tablets USP, 50 mg. The reason for recall is presence of foreign tablets/ capsules ‘customer complaint that a bottle of atenolol 50 mg tablets USP contained a paroxetine 20 mg tablet’. Atenolol tablets are used for treatment of hypertension. The firm initiated nationwide recall in the USA and Puerto Rico recall is also a class II recall.

As per the United States Food and Drug Administration (USFDA), a class II recall is initiated ‘in a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.

Zydus Lifesciences Share Price

984.75 -8.45 (-0.85%)
14-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.25
Dr. Reddys Lab 5861.00
Cipla 1356.95
Zydus Lifesciences 984.75
Lupin 1635.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.